CannaPharmaRX
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $3,688,456 over the previous period. Total operating expenses were $1,578,505.
Profit Margin
| 2014 | 0 | -3.97M | |
|---|---|---|---|
| 2015 | 0 | -11.74M | |
| 2016 | 0 | -1.00M | |
| 2017 | 0 | -6.63K | |
| 2018 | 0 | -3.09M | |
| 2019 | 0 | -24.92M | |
| 2020 | 0 | -22.18M | |
| 2021 | 0 | -10.33M | |
| 2022 | 0 | -8.53M | |
| 2023 | 0 | 3.68M |
CPMD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 65.56K | 294.93K | 14.36K | 128.50K | 129.03K | 0 | 0 | 0 | 12.03K | 0 |
Gross profit | -65.56K | -294.93K | -14.36K | -128.50K | -129.03K | 0 | 0 | 0 | -12.03K | 0 |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 589.78K |
Selling and marketing | 243.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.57M | 5.21M | 2.61M | 4.63M | 2.98M | 532.77K | 6.63K | 1.00M | 11.45M | 2.02M |
Operating income | -1.58M | -5.21M | -2.99M | -14.48M | -15.97M | -954.31K | -6.63K | -1.00M | -11.45M | -3.97M |
Other income (expenses), net | 5.26M | -1.02M | -5.83M | -5.40M | -4.47M | -421.48K | 0 | 4.06K | -90.47K | -1.97M |
Income before tax | 3.68M | -8.53M | -8.83M | -19.89M | -20.45M | -3.09M | -6.63K | -1.00M | -11.74M | -3.97M |
Income tax expense | 0 | 2.69M | 1.50M | 2.29M | 4.47M | 2.14M | -6.63K | 423 | 2.72K | 1.95M |
Net income | 3.68M | -8.53M | -10.33M | -22.18M | -24.92M | -3.09M | -6.63K | -1.00M | -11.74M | -3.97M |
Earnings per share | ||||||||||
Basic EPS | 0.01 | -0.04 | -0.14 | -0.55 | -0.8 | -0.17 | -0.00 | -0.05 | -0.77 | -0.36 |
Diluted EPS | 0.01 | -0.04 | -0.14 | -0.55 | -0.8 | -0.17 | -0.00 | -0.05 | -0.77 | -0.36 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |